HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

Plant-Based Vaccines

Plant-Based Vaccines

Plant-based vaccines represent an innovative approach to vaccine development, utilizing plants as bioreactors for producing antigens. This method harnesses the natural ability of plants to synthesize complex proteins, enabling the mass production of vaccine components that can stimulate an immune response. Plant-derived vaccines offer several advantages, including ease of production, cost-effectiveness, and stability at ambient temperatures, which is crucial for distribution in developing regions. Additionally, the use of plants minimizes the risk of contamination associated with traditional vaccine production methods. Research is ongoing to optimize the efficacy and delivery of these vaccines, with the potential to combat diseases in both humans and animals.

Committee Members
Speaker at GPB 2027 - Abdul Khalil Gardezi

Abdul Khalil Gardezi

Colegio de Posgraduados, Mexico
Speaker at GPB 2027 - K R Aneja

K R Aneja

Kurukshetra University, India
Speaker at GPB 2027 - Mary Cole

Mary Cole

The University of Melbourne, Australia
GPB 2027 Speakers
Aparna B Gunjal

Aparna B Gunjal

Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce

Anna Ponce

Bethune-Cookman University, United States
Hillary Jean Pierre

Hillary Jean Pierre

Department of Pharmaceutics, United States

Submit your abstract Today

WhatsApp